MassDevice1h
Solventum hires chief strategy officer out of Zimmer Biomet
Solventum has appointed former Zimmer Biomet executive Rachel Ellingson as chief strategy and corporate development officer.
Solventum sells purification business for $4.1B to pay down debt
M health care spinoff Solventum is selling its purification business to Thermo Fisher Scientific for $4.1 billion in cash to ...
Solventum Co. (NYSE:SOLV) Receives $74.71 Consensus Target Price from Brokerages
Solventum Co. (NYSE:SOLV – Get Free Report) has been assigned an average rating of “Hold” from the eleven brokerages that are currently covering the company, MarketBeat.com reports. One research ...
Solventum Stock Jumps After $4.1B Deal With Thermo Fisher
Shares of Solventum jumped Tuesday and led S&P 500 gainers intraday after medical device maker Thermo Fisher Scientific said ...
Solventum price target raised to $82 from $70 at Mizuho
Mizuho raised the firm’s price target on Solventum (SOLV) to $82 from $70 and keeps a Neutral rating on the shares following the Q4 report. The ...
Solventum In The Early Stages Of A Multiyear Turnaround Effort
Solventum faces significant challenges in its turnaround, including slow-growing core businesses, share loss, and margin ...
Solventum Corp. sells unit to Thermo Fisher for $4.1B
Solventum Corp., 3M’s medtech spinoff, has sold its purification and filtration business to Massachussetts-based Thermo ...
Thermo Fisher to buy Solventum’s purification and filtration unit for $4.1B
Thermo Fisher Scientific agreed to pay about $4.1 billion in cash to acquire Solventum’s purification and filtration business ...
Solventum price target raised to $75 from $73 at Wells Fargo
Wells Fargo raised the firm’s price target on Solventum (SOLV) to $75 from $73 and keeps an Equal Weight rating on the shares. The Q4 beat was ...
Solventum Corp. stock falls Friday, underperforms market
Shares of Solventum Corp. shed 4.42% to $79.75 Friday, on what proved to be an all-around positive trading session for the ...